From: Alice Jacobs Nesselrodt :< => To: Alice Jacobs Nesselrodt Subject: IMDx receives 3rd FDA clearance and relocates HQ to Waltham Date: Tue, 12 Nov 2013 21:14:41 +0000 Atta

From: Alice Jacobs Nesselrodt To: Alice Jacobs Nesselrodt Subject: IMDx achieves 4th FDA clearance--QIAGEN anus C difficile QS-RGQ MDx--a test for a serious healthcare-associated

t IMDx can offer a diagnostic solution to aid in the identification of vancomycin-resistant colonization in hospital settings in the U.S.," says Dr. Alice Jacobs Nesselrodt, Chairman and CEO of IMDx. "FDA clearance of the IMDx VanR for Abbott m2000 assay is a step toward the fulfillment of IMDx's mission to make clinic

This is in addition to other 500K. Please let's discuss when we meet next week. Can't wait to see you! Thank you Boris Original Message From: Alice Jacobs Nesselrodt Sent: Thursday, October 17, 2013 7:50 AM To: Boris Nikolic Subject: FW: Boris Some additional info Alice Jacobs Nesselrodt, M.D. Chairman & CEO

https://static.li=dn.comiscds/common/u/imgjemailiarrow_right_blue.png> <https://media.licdn.coqmprimprishrinknp_100_100/01/005/0b4/2ff/147bf43.jpg> Alice Jacobs Nesselrodt <https://www.linkedin.=om/e/v2?e=3ms54r-icvo3ucy- 69&t=npv&midToken=AQHVyClEjRzxXVA&a=p;ek=wylo_abook&primaryAction=ADD_TO_NETWORK&authType=name&a =